Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Subject
Sign on to:
My Account
Receive email
updates
Edit Profile
CMU Intellectual Repository
Browsing by Author Lalita Sathitsamitphong
Jump to:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
issue date
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 6 of 6
Issue Date
Title
Author(s)
1-Apr-2022
Clinical outcomes and screening for organ involvement in pediatric Langerhans cell histiocytosis in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group
Chalinee Monsereenusorn
;
Kunanya Suwannaying
;
Piti Techavichit
;
Lalita Sathitsamitphong
;
Patcharee Komvilaisak
;
Piya Rujkijyanont
;
Panya Seksarn
;
Pimlak Charoenkwan
;
Samart Pakakasama
1-Jan-2018
Novel mutations in SPTA1 and SPTB identified by whole exome sequencing in eight Thai families with hereditary pyropoikilocytosis presenting with severe fetal and neonatal anaemia
Chupong Ittiwut
;
Rungrote Natesirinilkul
;
Fuanglada Tongprasert
;
Lalita Sathitsamitphong
;
Chane Choed-amphai
;
Kanda Fanhchaksai
;
Pimlak Charoenkwan
;
Kanya Suphapeetiporn
;
Vorasuk Shotelersuk
30-Mar-2020
Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): Rationale and design of the ESMMO trial
Nut Koonrungsesomboon
;
Nuttapong Ngamphaiboon
;
Natavudh Townamchai
;
Pimpisa Teeyakasem
;
Chaiyut Charoentum
;
Pimlak Charoenkwan
;
Rungrote Natesirinilkul
;
Lalita Sathitsamitphong
;
Touch Ativitavas
;
Parunya Chaiyawat
;
Jeerawan Klangjorhor
;
Suradej Hongeng
;
Dumnoensun Pruksakorn
1-Jan-2019
A randomized, open-labeled, prospective controlled study to assess the efficacy of frontline empirical intravenous piperacillin/tazobactam monotherapy in comparison with ceftazidime plus amikacin for febrile neutropenia in pediatric oncology patients
Ruchirek Kamonrattana
;
Lalita Sathitsamitphong
;
Worawut Choeyprasert
;
Pimlak Charoenkwan
;
Rungrote Natesirinilkul
;
Kanda Fanhchaksai
1-Sep-2022
Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group
Kunanya Suwannaying
;
Chalinee Monsereenusorn
;
Piya Rujkijyanont
;
Piti Techavichit
;
Kamon Phuakpet
;
Pongpak Pongphitcha
;
Su on Chainansamit
;
Thirachit Chotsampancharoen
;
Angkana Winaichatsak
;
Chanchai Traivaree
;
Lalita Sathitsamitphong
;
Somjai Kanjanapongkul
;
Patcharee Komvilaisak
;
Kleebsabai Sanpakit
;
Apichat Photia
;
Panya Seksarn
;
Surapon Wiangnon
;
Suradej Hongeng
1-Sep-2022
Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand
Kunanya Suwannaying
;
Piti Techavichit
;
Patcharee Komvilaisak
;
Napat Laoaroon
;
Nattee Narkbunnam
;
Kleebsabai Sanpakit
;
Kanhatai Chiengthong
;
Thirachit Chotsampancharoen
;
Lalita Sathitsamitphong
;
Chalongpon Santong
;
Panya Seksarn
;
Suradej Hongeng
;
Surapon Wiangnon